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Abstract
Background: Patients with cervical radicular syndrome due to disc herniation refractory to conservative treatment are 
offered surgical treatment. Anterior cervical discectomy is the standard procedure, often in combination with 
interbody fusion. Accelerated adjacent disc degeneration is a known entity on the long term. Recently, cervical disc 
prostheses are developed to maintain motion and possibly reduce the incidence of adjacent disc degeneration. A 
comparative cost-effectiveness study focused on adjacent segment degeneration and functional outcome has not 
been performed yet. We present the design of the NECK trial, a randomised study on cost-effectiveness of anterior 
cervical discectomy with or without interbody fusion and arthroplasty in patients with cervical disc herniation.
Methods/Design: Patients (age 18-65 years) presenting with radicular signs due to single level cervical disc herniation 
lasting more than 8 weeks are included. Patients will be randomised into 3 groups: anterior discectomy only, anterior 
discectomy with interbody fusion, and anterior discectomy with disc prosthesis. The primary outcome measure is 
symptomatic adjacent disc degeneration at 2 and 5 years after surgery. Other outcome parameters will be the Neck 
Disability Index, perceived recovery, arm and neck pain, complications, re-operations, quality of life, job satisfaction, 
anxiety and depression assessment, medical consumption, absenteeism, and costs. The study is a randomised 
prospective multicenter trial, in which 3 surgical techniques are compared in a parallel group design. Patients and 
research nurses will be kept blinded of the allocated treatment for 2 years. The follow-up period is 5 years.
Discussion: Currently, anterior cervical discectomy with fusion is the golden standard in the surgical treatment of 
cervical disc herniation. Whether additional interbody fusion or disc prothesis is necessary and cost-effective will be 
determined by this trial.
Trial Registration: Netherlands Trial Register NTR1289
Background
Anterior cervical discectomy (ACD) is the basic surgical
treatment of patients with radicular pain caused by cervi-
cal disc herniation. In 1958, Cloward, Smith and Robin-
son first described anterior cervical decompression with
the use of autologous iliac crest interbody graft
(ACDF)[1]. Shortly after, Hirsch debated the necessity of
interbody fusion[2]. The results of various prospective
randomised trials suggest that interbody fusion may not
be necessary in all cases, although due to methodological
flaws no solid conclusions can be drawn[3-9]. The
Cochrane Review even mentioned advantages of anterior
discectomy only (e.g. costs, operation time and return to
work)[10].
At present, ACDF is defined as the golden standard for
cervical disc herniation to maintain disc height, cervical
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alignment, and promote bony fusion. However, arthrode-
sis of a motion segment will lead to increased degenera-
tive changes at the adjacent level. The concept of
accelerated adjacent disc degeneration (AADD) is widely
discussed and Hilibrand et al. reported an annual inci-
dence of 2.9% symptomatic AADD after fusion[11].
The main rationale of artificial disc replacement is
motion preservation with subsequent prevention of adja-
cent disc degeneration. Various prospective randomised
trials have shown that cervical disc prosthesis is a safe
and reliable alternative to cervical fusion[12-17]. How-
ever, limited studies have focused on symptomatic AADD
and the follow-up period is short[18,19].
In the NEtherlands Cervical Kinematics (NECK) trial,
we will randomly and blindly compare anterior cervical
discectomy  sec  (ACD), with anterior discectomy with
fusion (ACDF), and anterior discectomy with disc pros-
thesis (ACDP) in 3 treatment groups. We hypothesise a
difference in symptomatic adjacent level disease in favour
of disc prosthesis and better clinical outcome and self-
assessment measured by the Neck Disability Index (NDI).
As such we will evaluate the clinical appropriateness and
superiority of disc prosthesis on one hand, cervical fusion
on the other hand, and compare this to discectomy with-
out any implant. Moreover, we will identify possible sub-
groups of patients who will substantially benefit from one
of the allocated surgical treatments.
Methods/Design
We designed an observer and patient blinded randomised
cost-effectiveness trial in the treatment of cervical disc
herniation in which three surgical techniques are com-
pared in a parallel group design. Adjacent level disease
will be used as primary outcome measure and NDI as
secondary outcome. As such we will evaluate the clinical
appropriateness and superiority of disc prosthesis on one
hand, cervical fusion on the other hand, and compare this
to discectomy without any implant. The follow-up period
will last 5 years.
In order to collect enough patients, a multicenter
design is necessary. The clinical centers that are planned
to recruit patients into the NECK trial are: Medical Cen-
ter Haaglanden, The Hague; Leiden University Medical
Center; University Medical Center Groningen; Medical
Center Alkmaar; and University Medical Center Maas-
tricht. The protocol was approved by the ethics commit-
tee/IRB in each participating hospital.
The primary question of the NECK trial is whether
ACDP has a lower incidence of symptomatic adjacent
disc degeneration compared to ACD and ACDF. Symp-
tomatic adjacent level disease is defined as development
of new symptoms (i.e. neck pain, radiculopathy, or myel-
opathy) referable to a motion segment adjacent to the site
of the previous anterior surgery. In addition, we want to
identify certain subgroups that may benefit more of one
of the allocated treatments.
Patients
All patients between 18 and 65 years with monoradicular
symptoms in one or both arms lasting more than 8 weeks
are eligible for the NECK trial. MRI must confirm cervi-
cal disc herniation and/or osteophyte in accordance with
clinical symptoms. Additional inclusion and exclusion
criteria are listed in Table 1.
Patients are referred by a neurologist with MRI of the
cervical spine. During the first visit to the neurosurgical
outpatient clinic, the patient's history and a standard neu-
rological examination will be documented. Conform our
selection criteria, the neurosurgeon decides whether a
patient is eligible for the NECK trial. The study will be
explained to the patient and, in case of a positive reaction,
an appointment is made with one of the research nurses.
Because the patient needs some time to consider partici-
pation, the first visit to the research nurse is planned after
at least 2 days. After informed consent, the question-
naires, outcome measures, and baseline variables are
recorded.
Randomisation procedure
Patients will be randomly allocated to ACD, ACDF, or
ACDP. Randomisation will take place on the operating
room within 6 weeks after the first visit to the research
nurse. A randomisation list is prepared for every partici-
pating hospital-nurse combination. Variable sized blocks
of random numbers are formed to ensure equal distribu-
tion of the randomisation treatments over hospitals and
research nurses. The data manager, who is not involved in
the selection and allocation of patients, will prepare
coded, sealed envelopes containing the treatment alloca-
tion. In the operating room, after induction of anaesthe-
sia, the surgeon will open the envelope and the allocated
treatment will be performed. Patients and research
nurses will be kept blinded for the allocated treatment for
2 years.
Intervention
Patients will be randomised into anterior discectomy sec
(group A), anterior discectomy with interbody fusion
(group B), and anterior discectomy with arthroplasty
(group C). The participating surgeons have large experi-
ence in all three techniques. A standardized Case Record
Form (CRF) will register the surgeon's findings and this
CRF, together with the randomisation envelope, will be
returned to the data center in a sealed envelope.
(A) Anterior cervical discectomy (ACD)
All patients will be positioned supine with their neck in
neutral position or slightly extended under general anaes-
t h e s i a .  T h e  a f f e c t e d  c e rv i c a l  d i s c  l e v e l  w i l l  b e  v e r i f i e dArts et al. BMC Musculoskeletal Disorders 2010, 11:122
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with fluoroscopy. A small transverse incision will be
made either on the right side or the left side depending on
the surgeon's preference. Medial to the carotic sheath, the
pre-vertebral space will be opened and the anterior cervi-
cal spine will be exposed. Two distraction pins and the
Caspar spreader will be placed in the affected segment. A
standard anterior discectomy with the aid of microscope
or loupe/headlight magnification (depending on the sur-
geon's preference) will be performed in all cases. The pos-
terior longitudinal ligament will be opened and the nerve
root and dura will be decompressed adequately. If
required a vacuum drain will be placed and the wound
will be closed in layers.
(B) Anterior cervical discectomy with interbody fusion 
(ACDF)
Once the anterior discectomy has been performed, an
interbody cage filled with bone substitute will be placed
within the intervertebral space under fluoroscopic guid-
ance. The type of cage depends on the surgeon's prefer-
ence and daily practice. To prevent pain from the iliac
crest, no autologous bone will be used.
(C) Anterior cervical discectomy with disc prosthesis (ACDP)
The device used in the present trial is the Activ-C Flat
artificial disc (B. Braun Aesculap, Germany)[20]. After
the standard anterior discectomy is performed, the
implant size will be determined and the endplates will be
prepared for proper fitting of the prosthesis. The device
will be inserted under slight distraction and fluoroscopic
guidance. Whenever, for surgical-technical reasons, it is
not possible to implant the disc prosthesis, an interbody
fusion will be performed. Whenever this is impossible as
well, only discectomy will be performed.
All patients will be encouraged to mobilise as soon as
possible without a collar. Hospital admission will be 1-3
days, depending on the usual care of the participating
hospital. Patients are stimulated to resume home activi-
ties and work as soon as possible.
Baseline data
Baseline assessment includes demographics, hobbies,
sports, work status, smoking status, neck and arm pain
history of patient and family, medical history and co-
morbidity, body mass index, and neurological signs and
symptoms. The patient's satisfaction at work will be reg-
istered. The treatment preference of patient, surgeon and
research nurse will also be assessed.
Outcome assessment
We will assess the below described validated outcome
parameters. Patients will not be informed about their
previous scores. Follow-up examination will take place at
8, 26, 52, 104 and 260 weeks after randomisation. Patients
will be neurologically examined and questionnaires will
Table 1: Selection criteria for trial eligibility.
Inclusion criteria
Age 18 - 65 years
Radicular signs and symptoms in one or both arms
At least 8 weeks prior conservative treatment
Radiographic diagnosis of cervical disc herniation and/or osteophyte at 1 level (C3-C4 to C7-T1) in accordance with clinical signs and 
symptoms
Informed consent
Exclusion criteria
Previous cervical surgery (either anterior or posterior)
No motion of the index level on dynamic studies
Increased antero-posterior motion of the index level on dynamic studies (>3 mm)
Involved disc level fused or very narrow (central <3 mm)
Severe segmental kyphosis of involved disc level (>3 degrees)
Neck pain only
Symptoms and signs of chronic myelopathy
Infection, bone disease, neoplasm or trauma of the cervical spine
Spinal anomaly (Klippel-Feil, Bechterew, OPLL)
Severe mental or psychiatric disorder
Inadequate Dutch language
Planned (e)migration abroad in the year after inclusionA
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Table 2: Data collection and outcome measures.
Intake 
surgeon
Intake 
research 
nurse
Informed 
consent
Surgery Follow-up 
2 weeks
Follow-up 
4 weeks
Follow-up 
8 weeks
Follow-up 
12 weeks
Follow-up 
26 weeks
Follow-up 
52 weeks
Follow-up 
104 weeks
Follow-up 
156 weeks
Follow-up 
208 weeks
Follow-up 
260 weeks
Visit 1 2 3 4 5 6 7 8 9
Inclusion/
exclusion criteria
X
Informed consent X
Treatment 
preference
XX
Expected recovery X X
Demographics & 
diagnosis
XX
Basic physical 
examination
X
Neurological 
examination
XX X X X X X X
Randomisation X
Dynamic X-ray X X X X X X X
MRI X XX
CT X XX
N D I X XXXXXXXXXX
McGill X X X X X X X X X X X
VAS arm and neck X X X X X X X X X X X
S F - 3 6 X XXXXXXXXXX
H A D S X X XXXXXX
K a r a s e k X XXXXXXXXXX
L i k e r t XXXXXXXXXX
Macnab XX X X X
E u r o Q o l  a n d  V A S X XXXXXXXXXX
Cost diaries XXXXXXX
Complications X X X X X X X
Re-operation XX X X X XArts et al. BMC Musculoskeletal Disorders 2010, 11:122
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be filled in. At 2, 4, 12, 156 and 208 weeks after randomis-
ation, questionnaires will be sent by mail (Table 2).
Primary outcome measure
Accelerated adjacent disc degeneration (AADD).
Although the evaluation of cervical disc degeneration is
very important in this clinical setting, there is no estab-
lished standardized nomenclature. Radiographic degen-
erative changes at the superior and inferior adjacent
levels will be recorded by means of X-ray at intake and
each follow-up moment. At 2 and 5 years follow-up both
CT and MRI of the cervical spine will be performed. In
this trial we will use a recently developed MRI-based
grading system for cervical intervertebral disc degenera-
tion, which has been shown reliable[21](Table 3) It is of
uppermost importance that radiological adjacent level
disease will be accompanied by concomitant complaints,
but we will evaluate radiographic adjacent level disease
without symptoms as well.
Secondary outcome measures
1) Neck Disability Index (NDI)
The NDI is a 10-item questionnaire on 3 different
aspects; pain intensity, daily work related activities and
non-work related activities. Each item is scored from 0 to
5 and the total score ranges from 0 (best score) to 50
(worst score). The NDI is a modification of the Oswestry
Low Back Pain Index and has been shown to be reliable
and valid for patients with cervical pathology[22-24].
2) Short-Form 36 (SF-36)
This is a generic health status questionnaire that can eas-
ily be filled out at home. The questionnaire consists of 36
items on physical and social status of the patient subdi-
vided in 8 domains; 1) physical functioning, 2) physical
restrictions, 3) emotional restrictions, 4) social function-
ing, 5) somatic pain, 6) general mental health, 7) vitality
and 8) general health perception. The questions are
scored on a scale of 0 (worst health) to 100 (ideal health).
This questionnaire has been used frequently and is vali-
dated in surgical studies on spinal column pathology[25-
27].
3) Pain
Pain intensity, measured by Visual Analogue Score (VAS)
of arm and neck and McGill pain Questionnaire is chosen
as secondary outcome measure.
VAS arm pain
This parameter will measure the experienced pain inten-
s i t y  i n  t h e  a r m  d u r i n g  t h e  w e e k  b e f o r e  v i s i t i n g  t h e
research nurse. Pain will be assessed on a horizontal 100
mm scale varying from 0 mm (no pain) to 100 mm (worst
pain imaginable). Patients do not see the results of earlier
assessments and will score the pain experienced at the
visit. Reliability, validity and responsiveness of VAS have
been shown[28].
VAS neck pain
Since many patients with radicular arm pain have neck
pain as well, we will also measure the intensity of neck
pain.
McGill Pain Questionnaire
The McGill Pain score consists of 4 parts: 1) quality and
intensity of pain, 2) effects of pain on daily activities, 3)
VAS, and 4) distribution and course of pain. The McGill
pain score is shown to be highly effective to evaluate the
effects of treatment on pain[29]. The Dutch version of
McGill pain score will be used in this study[30].
4) Karasek Job Content Questionnaire
The Job Content Questionnaire is developed by Karasek
to measure the on-the-job impact of chronic health prob-
lems and/or treatment[31]. We will use the Dutch version
of the Karasek which has been shown reliability and
validity[32].
5) Hospital Anxiety Depression Scale (HADS)
The HADS is a self-assessment scale which is developed
to detect anxiety and depression in patients attending a
medical clinician and has been shown reliable and
valid[33]. The HADS consists of a 7-item depression scale
and a 7-item anxiety scale. The score ranges from 0-21
with a high score being indicative for depression/anxiety.
7) Perceived recovery
This is a 7-point Likert scale measuring the perceived
recovery, varying from "complete recovery" to "worse
Table 3: MRI-based grading system for cervical intervertebral disc degeneration.
Grade Nucleus signal intensity Nucleus structure Distinction of nucleus and annulus Disc height
I Hyperintense Homogenous, white Clear Normal
II Hyperintense Inhomogenous with horizontal band, white Clear Normal
III Intermediate Inhomogenous, grey to black Unclear Normal to decreased
IV Hypointense Inhomogenous, grey to black Lost Normal to decreased
V Hypointense Inhomogenous, grey to black Lost CollapsedArts et al. BMC Musculoskeletal Disorders 2010, 11:122
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than ever". This outcome scale has been used in previous
studies and is regarded valid and responsive to
change[34]. Complete recovery and almost complete
recovery are defined as good result. Next to this global
self-assessment, a job and hobby specific Likert will be
scored. During the intake of the study the patient will be
asked to rank their 5 most important functional disabili-
ties in daily life, which they can use in their own evalua-
tion overall and in separate items. Moreover, the
e x p e c t e d  r e c o v e r y  f r o m  b o t h  p a t i e n t ,  s u r g e o n  a n d
research nurse will be evaluated.
8) Utility measurements
The EuroQol (EQ-5D) measures 5 dimensions (mobility,
self-care, daily activities, pain/discomfort, anxiety/
depression), on a 3 point scale (no, some, or extreme
problems). For each health state described by the
patients, a utility score can be calculated that reflects
society's valuation of that health state. The Dutch tariff
for the EQ-5D will be used[35]. Similarly, SF-6D utilities
will be calculated from the SF-36 profiles[36]. Whereas
the EQ-5D and SF-6D provide society's assessment of the
patients' health, the patients themselves will also assess
their own health on VAS, ranging from 0.0 (as bad as
death) to 1.0 (optimal health). Both the EQ-5D and the
VAS will be reported in questionnaires filled out at home.
Other outcome measures
1) Costs
The direct medical costs of hospital admission (fixed
costs per admission, and variable costs per admission
day) and surgery (including personnel and implants) will
be estimated in all participating hospitals for cost-analy-
sis. Using cost diaries, the patients will register other
medical care (including physiotherapy, visits to general
practitioners and medical specialists, nursing care, and
medication) and non-medical costs (including out-of-
pocket expenses, domestic help, and absenteeism). Each
diary will cover 3 months and the research nurse will go
through the diary with the patient on every follow-up
visit, throughout the study period of 2 years. Costs will be
calculated using standard prices, including time and
travel costs [37].
T o estimate the indirect costs, like productivity costs,
patients will register absenteeism in the diary and the
research nurse will register the patient's work situation,
work efficiency, and gross income on follow-up
moments. Absenteeism will be valued to the friction-cost
method.
2) Incidence of re-operations
In previous studies concerning spine surgery the inci-
dence of re-operations has been used to assess outcome.
Also in this study, we will assess the incidence of re-oper-
ation. Every surgical re-exploration in both groups will be
considered as re-operation.
3) Complications
A systematic assessment of complications (including
wound infection, deep venous thrombosis, urine tract
infection, haematoma, progressive neurological deficit,
dysphagia, and hoarseness) will be carried out by the sur-
geon and research nurse. Surgeons will also document
perioperative complications like cerebrospinal fluid leak-
age, vascular injury, nerve root damage, and malposition
of the implant.
4) Radiographic evaluation
Besides adjacent disc degeneration (primary outcome
measure), we will also evaluate the cervical curvature,
segmental motion, displacement or migration of the
implant, and heterotopic ossification using the classifica-
tion of McAfee[38].
Sample size
The sample size calculation is based on the hypothesis
that the incidence of symptomatic adjacent disc disease
after cervical disc prosthesis is equal to anterior discec-
tomy with or without interbody fusion. Based on the lit-
erature, the annual incidence of symptomatic adjacent
disc disease after ACDF and ACDP is 7% and 0.65%
respectively[18]. However, in that trial only 74 patients
underwent disc arthroplasty and the probability of adja-
cent disc degeneration may be higher. Therefore, in our
study, we assume an annual incidence of adjacent disc
degeneration of 2% after arthroplasty and 7% after inter-
body fusion for the power calculations. We require a
power of 90%, a significance level of 0.05, and assume
committed accrual duration of 3 years. We plan a group
sequential design with 2 interim analyses using a survival
model approach for "time-to-degeneration" and a test-
for-superiority approach. The East software (version 5) is
used for the design of this study. The assumptions (2% vs.
7% to be detected) correspond to a Hazard Ratio of 0.28.
With an accrual of 150 patients per year during 3 years,
the required power is attained for a two-group compari-
son. Since we intend to perform two 2-group compari-
sons separately, we need 1.5*450 = 675 patients in total.
Assuming a loss to follow-up of 10%, a total of 750
patients are needed. The interim analyses are performed
only for the main comparison of ACDF versus ACDP.
Stopping is allowed for futility as well as efficacy and fol-
lows prespecified alpha and beta spending rules.
Data Analysis
The data will be analysed according to the stopping rules,
i.e. after approximately 1.8, 2.6 and 3.2 years under H0
and 2.2, 3.2 and 4.2 years under H1. The actual analysis
times depend on the number of events observed (15, 30Arts et al. BMC Musculoskeletal Disorders 2010, 11:122
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and 45). This establishes an answer to the main objectives
in terms of the comparison of ADCF to ADCP. Long-
term analyses of all results will be conducted irrespective
of an early achievement of futility or efficacy establishing
a comparison at 52, 104, 156, 208 and 260 weeks. How-
ever, these analyses will be performed after the final anal-
ysis of the trial has reached the conclusion of efficacy or
futility. For all analyses, assessments performed at the
first outpatient visit will be taken as baseline. Baseline
comparability will be analysed by descriptive statistics to
determine whether randomisation was successful. Base-
line measurements will be used as covariates in the analy-
ses to increase power. Differences in outcome measures
between the 2 pairs of groups, together with 95% confi-
dence intervals, will be calculated. All data are analysed
according the "intent-to-treat principle".
The primary research objective will be tested using two
likelihood ratio tests for the hazard ratio's, one for the
comparison to ACD and one to ACDF. In case of homo-
geneity of effects, a pooled effect (adjusting for interbody
fusion) will be reported. Otherwise the two analyses will
be reported separately. The secondary outcome continu-
ous measures will be compared using two t-tests in the
s a m e  w a y  ( o r  n o n - p a r a m e t r i c  c o u n t e r p a r t s  i n  c a s e  o f
non-symmetrical or distributions with outliers), possibly
after transformations of skewed distributions.
On the other hand, repeated measurements analyses of
variance for the secondary outcome measures (the con-
tinuous outcome scales) will also be performed in order
to compare the evolving patterns over time.
In addition, an explorative subgroup analysis is con-
ducted to investigate whether the treatment effect varies
over specific subgroups of patients (Table 4).
Data will be stored via the internet-based secure data
management system "ProMISe" of the department of
Medical Statistics and Bio Informatics[39]. The analyses
will be carried out using appropriate statistical software
(e.g. SPSS).
Discussion
Since the introduction of anterior approach of the cervi-
cal spine by Cloward, Robinson and Smith[1], a dispute
has started about the best surgical treatment. The pur-
pose of all surgical procedures is removal of the interver-
tebral disc in order to decompress the nerve root and
alleviate radicular pain. However, cervical instability and
segmental collapse with recurrent radicular pain has been
documented after anterior discectomy. For this reason,
most surgeons in general hospitals perform anterior dis-
cectomy with interbody fusion while most academic sur-
geons perform a discectomy sec  a s  a  r e s u l t  o f  l a c k  o f
evidence. The results of various randomised trials suggest
that interbody fusion may not be necessary in all cases[3-
9]. In fact, The Cochrane Review even mentioned advan-
tages of anterior discectomy only; lower costs, shorter
operation time and faster return to work[10].
One of the main drawbacks of arthrodesis of a motion
segment is increased load and stress at the levels adjacent
to the fusion site. The concept of accelerated adjacent
disc degeneration (AADD) is widely discussed. Hilibrand
et al. reported a large retrospective study of patients who
underwent anterior discectomy with fusion. Symptom-
atic adjacent level degeneration occurred at a relative
constant incidence of 2.9% annually[11]. However, data
on asymptomatic patients suggest that intervertebral disc
degeneration is a physiological process, which may be
accelerated by interbody fusion[40,41].
The rationale of artificial disc replacement, mainly
industry driven, is motion preservation with subsequent
prevention of adjacent disc degeneration. Various pro-
spective randomised trials have shown that cervical disc
prosthesis is a safe and reliable alternative to cervical
fusion[12-17]. Data focused on adjacent disc degenera-
tion after arthroplasty is limited, but the incidence of
AADD seems low[18,19]. In the largest randomised trial
on cervical disc prosthesis by Mummaneni et al., radio-
graphic evaluation of adjacent level degeneration was not
assessed[16]. Moreover, the follow-up period in all con-
ducted studies is too short for proper evaluation of
AADD.
The primary concern on studies focused on AADD, is
the low incidence of events. As outlined in our sample
size calculation, 750 patients will need to be randomised
to elucidate the dispute on prevention of AADD in disc
arthroplasty studies. In addition, an extra treatment arm
of anterior discectomy without fusion will be needed to
justify the high costs of cages or disc prostheses. Bartels
et al. have published a similar protocol on cervical disc
herniation in which 3 surgical strategies are com-
pared[42]. However, the NDI was taken as primary out-
come measure. Therefore, in our opinion, the number of
Table 4: Selected prognostic variables for subgroup 
analysis.
Demographic variables
Age ≤ 40 years versus > 40 years
Women versus men
High education versus low education
Anamnestic and neurological variables
Neck pain versus no neck pain
Quetelet index ≤ 30 versus > 30
Radiological variables
Uncovertebral osteophytes versus no osteophytes
Straight neck versus lordotic neck
Low disc (≤5 mm) versus high disc (>5 mm)Arts et al. BMC Musculoskeletal Disorders 2010, 11:122
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patients enrolled is not enough for scientific proof of pos-
sible reduced incidence of AADD after disc arthroplasty.
The NECK trial is designed to demonstrate the effec-
tiveness and security of cervical disc prosthesis, focused
on adjacent segment degeneration and functional out-
c o m e .  A C D P  w i l l  b e  r a n d o m l y  a n d  b l i n d l y  c o m p a r e d
with ACD and ACDF. The only way to elucidate the dis-
pute on AADD prevention, is a 3 arm randomised trial
with large number of patients to be included. As such we
will evaluate the clinical appropriateness and superiority
of disc prosthesis on one hand, cervical fusion on the
other hand, and compare this to discectomy without any
implant.
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